These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 11922892)

  • 21. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlling myocardial matrix remodeling: implications for heart failure.
    Rao VU; Spinale FG
    Cardiol Rev; 1999; 7(3):136-43. PubMed ID: 10423664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling.
    Li W; Gan R; Sun G
    Chin Med J (Engl); 2002 Aug; 115(8):1166-9. PubMed ID: 12215284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium.
    Wilson EM; Spinale FG
    Ann Med; 2001 Dec; 33(9):623-34. PubMed ID: 11817657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis of ventricular remodeling: role of the myocyte.
    Li F; Wang X; Yi XP; Gerdes AM
    Curr Heart Fail Rep; 2004; 1(1):5-8. PubMed ID: 16036018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure.
    Li YY; Kadokami T; Wang P; McTiernan CF; Feldman AM
    Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H983-9. PubMed ID: 11834496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac matrix remodelling in congestive heart failure: the role of matrix metalloproteinases.
    Abou-Raya S; Naim A; Marzouk S
    Clin Invest Med; 2004 Apr; 27(2):93-100. PubMed ID: 15202828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
    Kassiri Z; Oudit GY; Sanchez O; Dawood F; Mohammed FF; Nuttall RK; Edwards DR; Liu PP; Backx PH; Khokha R
    Circ Res; 2005 Aug; 97(4):380-90. PubMed ID: 16037568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
    Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
    J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of chronic heart failure by dexamethasone is not associated with downregulation of leptin in rats.
    Xia QG; Na T; Guo YM; Bi YT; Zhang HY; Dai DZ
    Acta Pharmacol Sin; 2007 Feb; 28(2):202-10. PubMed ID: 17241522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
    Lindsey ML; Iyer RP; Jung M; DeLeon-Pennell KY; Ma Y
    J Mol Cell Cardiol; 2016 Feb; 91():134-40. PubMed ID: 26721597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
    Bourraindeloup M; Adamy C; Candiani G; Cailleret M; Bourin MC; Badoual T; Su JB; Adubeiro S; Roudot-Thoraval F; Dubois-Rande JL; Hittinger L; Pecker F
    Circulation; 2004 Oct; 110(14):2003-9. PubMed ID: 15451797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NO-cGMP and TNF-alpha counter regulatory system in blood: understanding the mechanisms leading to myocardial dysfunction and failure.
    Elahi M; Asopa S; Matata B
    Biochim Biophys Acta; 2007 Jan; 1772(1):5-14. PubMed ID: 17045464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
    Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
    Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?
    Ceconi C; Curello S; Bachetti T; Corti A; Ferrari R
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):25-30. PubMed ID: 9715820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruptions and detours in the myocardial matrix highway and heart failure.
    Deschamps AM; Spinale FG
    Curr Heart Fail Rep; 2005 Mar; 2(1):10-7. PubMed ID: 16036046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
    Timmers L; Sluijter JP; van Keulen JK; Hoefer IE; Nederhoff MG; Goumans MJ; Doevendans PA; van Echteld CJ; Joles JA; Quax PH; Piek JJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2008 Feb; 102(2):257-64. PubMed ID: 18007026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.